相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Hepatic fibrosis: 2022 Unmet needs and a blueprint for the future
Scott L. Friedman et al.
HEPATOLOGY (2022)
Fuzheng Xiaozheng prescription relieves rat hepatocellular carcinoma through improving anti-inflammation capacity and regulating lipid related metabolisms
Xia Li et al.
JOURNAL OF ETHNOPHARMACOLOGY (2022)
Transforming growth factor β latency: A mechanism of cytokine storage and signalling regulation in liver homeostasis and disease
Yujia Li et al.
JHEP REPORTS (2022)
Xiaoyaosan decoction alleviated rat liver fibrosis via the TGFβ/Smad and Akt/FoxO3 signaling pathways based on network pharmacology analysis
Yuan Zhou et al.
JOURNAL OF ETHNOPHARMACOLOGY (2021)
Traditional Chinese Medicine Ganshuang Granules Attenuate CCl4-Induced Hepatic Fibrosis by Modulating Gut Microbiota
Jie Zhao et al.
CHEMISTRY & BIODIVERSITY (2021)
Therapeutic Effect of Biejiaxiaozheng Pills on Carbon Tetrachloride-Induced Hepatic Fibrosis in Rats through the NF-κB/Nrf2 Pathway
Weibin Wu et al.
Gastroenterology Research and Practice (2021)
Si-Wu-Tang ameliorates fibrotic liver injury via modulating intestinal microbiota and bile acid homeostasis
Xiaoyong Xue et al.
CHINESE MEDICINE (2021)
Targeting Nestin+ hepatic stellate cells ameliorates liver fibrosis by facilitating TβRI degradation
Huaxin Chen et al.
JOURNAL OF HEPATOLOGY (2021)
Pharmacokinetics-based comprehensive strategy to identify multiple effective components in Huangqi decoction against liver fibrosis
Yahang Wang et al.
PHYTOMEDICINE (2021)
Comparison of four markers of hepatic fibrosis and hepatic function indices in patients with liver cirrhosis and hepatoma
Hong-Yu Ma et al.
ANNALS OF PALLIATIVE MEDICINE (2021)
TGFβ2 and TGFβ3 isoforms drive fibrotic disease pathogenesis
Tianhe Sun et al.
SCIENCE TRANSLATIONAL MEDICINE (2021)
Ursolic acid reverses liver fibrosis by inhibiting NOX4/NLRP3 inflammasome pathways and bacterial dysbiosis
Yuan Nie et al.
GUT MICROBES (2021)
Yiguanjian decoction inhibits macrophage M1 polarization and attenuates hepatic fibrosis induced by CCl4/2-AAF
Ying Xu et al.
PHARMACEUTICAL BIOLOGY (2021)
Molecular and cellular mechanisms of liver fibrosis and its regression
Tatiana Kisseleva et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2021)
Research Progress inAstragalus Membranaceusand Its Active Components on Immune Responses in Liver Fibrosis
Liu Yu-tong et al.
CHINESE JOURNAL OF INTEGRATIVE MEDICINE (2020)
Mechanisms of Fibrosis Development in NASH
Robert F. Schwabe et al.
GASTROENTEROLOGY (2020)
A Positive Feedback Loop of TET3 and TGF-β1 Promotes Liver Fibrosis
Yetao Xu et al.
CELL REPORTS (2020)
Advances in anti hepatic fibrotic therapy with Traditional Chinese Medicine herbal formula
Hui Li
JOURNAL OF ETHNOPHARMACOLOGY (2020)
A network pharmacology approach to investigating the mechanism of Tanshinone IIA for the treatment of liver fibrosis
Miao-Juan Shi et al.
JOURNAL OF ETHNOPHARMACOLOGY (2020)
Hepatic stellate cell autophagy inhibits extracellular vesicle release to attenuate liver fibrosis
Jinhang Gao et al.
JOURNAL OF HEPATOLOGY (2020)
Ursolic acid improves the bacterial community mapping of the intestinal tract in liver fibrosis mice
Sizhe Wan et al.
PEERJ (2020)
Liver fibrosis: Pathophysiology, pathogenetic targets and clinical issues
Maurizio Parola et al.
MOLECULAR ASPECTS OF MEDICINE (2019)
Formononetin ameliorates cholestasis by regulating hepatic SIRT1 and PPARα
Shu Yang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2019)
Noninvasive indicators predict advanced liver fibrosis in autoimmune hepatitis patients
Lingyan Liu et al.
JOURNAL OF CLINICAL LABORATORY ANALYSIS (2019)
ECM1 Prevents Activation of Transforming Growth Factor β, Hepatic Stellate Cells, and Fibrogenesis in Mice
Weiguo Fan et al.
GASTROENTEROLOGY (2019)
LECT2, a Ligand for Tie1, Plays a Crucial Role in Liver Fibrogenesis
Meng Xu et al.
CELL (2019)
Active Ingredients and Action Mechanisms of Yi Guan Jian Decoction in Chronic Hepatitis B Patients with Liver Fibrosis
Guangyao Li et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2019)
Ursolic Acid Improves Intestinal Damage and Bacterial Dysbiosis in Liver Fibrosis Mice
Si-Zhe Wan et al.
FRONTIERS IN PHARMACOLOGY (2019)
TGF-β in Hepatic Stellate Cell Activation and Liver Fibrogenesis-Updated 2019
Bedair Dewidar et al.
CELLS (2019)
Therapeutic Effect of Tanshinone IIA on Liver Fibrosis and the Possible Mechanism: A Preclinical Meta-Analysis
Qingji Ying et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2019)
Selected hepatoprotective herbal medicines: Evidence from ethnomedicinal applications, animal models, and possible mechanism of actions
Muhammad Ali et al.
PHYTOTHERAPY RESEARCH (2018)
Non-invasive assessments for liver fibrosis: The crystal ball we long for
Grace Lai-Hung Wong
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2018)
Liver fibrosis: Direct antifibrotic agents and targeted therapies
Detlef Schuppan et al.
MATRIX BIOLOGY (2018)
Ursolic Acid Attenuates Hepatic Steatosis, Fibrosis, and Insulin Resistance by Modulating the Circadian Rhythm Pathway in Diet-Induced Obese Mice
Eun-Young Kwon et al.
NUTRIENTS (2018)
Mechanisms of hepatic stellate cell activation
Takuma Tsuchida et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2017)
Ursolic acid suppresses TGF-β1-induced quiescent HSC activation and transformation by inhibiting NADPH oxidase expression and Hedgehog signaling
Shan-Shan Yu et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2017)
Carapax Trionycis extracts inhibit fibrogenesis of activated hepatic stellate cells via TGF-β1/Smad and NFκB signaling
Zuliang Hu et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
TGF-β signalling and liver disease
Isabel Fabregat et al.
FEBS JOURNAL (2016)
Yiguanjian decoction and its ingredients inhibit angiogenesis in carbon tetrachloride-induced cirrhosis mice
Ya-Ning Zhou et al.
BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE (2015)
Suppression of oxidative stress and improvement of liver functions in mice by ursolic acid via LKB1-AMP-activated protein kinase signaling
Yongbin Yang et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2015)
Daidzein exhibits anti-fibrotic effect by reducing the expresslions of Proteinase activated receptor 2 and TGFβ1/smad mediated inflammation and apoptosis in Bleomycin-induced experimental pulmonary fibrosis
Syamala Soumyakrishnan et al.
BIOCHIMIE (2014)
Liver fibrosis and repair: immune regulation of wound healing in a solid organ
Antonella Pellicoro et al.
NATURE REVIEWS IMMUNOLOGY (2014)
The Protective Effect of Glycyrrhetinic Acid on Carbon Tetrachloride-Induced Chronic Liver Fibrosis in Mice via Upregulation of Nrf2
Shaoru Chen et al.
PLOS ONE (2013)
Fibrosis-dependent mechanisms of hepatocarcinogenesis
David Y. Zhang et al.
HEPATOLOGY (2012)
Ursolic acid ameliorates hepatic fibrosis in the rat by specific induction of apoptosis in hepatic stellate cells
Xu Wang et al.
JOURNAL OF HEPATOLOGY (2011)
Chinese medicines as a resource for liver fibrosis treatment
Yibin Feng et al.
Chinese Medicine (2009)
Compound Astragalus and Salvia miltiorrhiza Extract exerts anti-fibrosis by mediating TGF-β/Smad signaling in myofibroblasts
Yan Yang et al.
JOURNAL OF ETHNOPHARMACOLOGY (2008)
Traditional Chinese medicine Bao Gan Ning increase phosphorylation of CREB in liver fibrosis in vivo and in vitro
Y Tan et al.
JOURNAL OF ETHNOPHARMACOLOGY (2006)